Tamoxifen Articles:

Tamoxifen Shockingly Found to Cause Aggressive Breast Cancer

Long-term Tamoxifen use, as widely promoted by oncologists for women following breast cancer, turns out to increase the risk of highly aggressive hormone receptor-negative breast cancer by 440%. This means that while Tamoxifen reduces the risk for less invasive estrogen positive cancer by 60%, it is at the same time putting many women in extreme peril.

Read More:  breast cancer, LeptiCardio Pack™, Leptin Control Pack®, Leptinal®, LeptiSlim®, Tamoxifen